Pictet Asset Management (Switzerland)’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-460	Closed	-$47.2K	–	1992
2023 Q1	$47.2K	Hold	460	–	–	﹤0.01%	1939
2022 Q4	$67K	Buy	+460	New	+$67K	﹤0.01%	1934
2021 Q4	–	Sell	-89,515	Closed	-$21.1M	–	1774
2021 Q3	$21.1M	Buy	+89,515	New	+$21.1M	0.02%	499